$0.0001
+0 (+0%)
At Close: Jul 31, 2026
Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels
09:53am, Tuesday, 16'th Mar 2021
Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos Planta
Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels
08:30am, Tuesday, 16'th Mar 2021
Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettosPlantation
Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials
08:30am, Thursday, 11'th Mar 2021
Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical tr
Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications
09:20am, Tuesday, 23'rd Feb 2021
Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validationPlantation, Florida--(Newsfile Corp. - February 23, 2
Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys
08:45am, Friday, 12'th Feb 2021
Plantation, Florida--(Newsfile Corp. - February 12, 2021) - Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the
Nutra Pharma Letter to Shareholders
10:25am, Tuesday, 12'th Jan 2021
Plantation, Florida, January 12, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-cou
Nutra Pharma Letter to Shareholders
10:22am, Tuesday, 12'th Jan 2021
Plantation, Florida--(Newsfile Corp. - January 12, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-co
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
09:20am, Wednesday, 18'th Nov 2020
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
09:15am, Wednesday, 18'th Nov 2020
Nutra Pharma is providing updates on their work in utilizing their platform technology as potential countermeasures against nerve agentsPlantation, Florida--(Newsfile Corp. - November 18, 2020) - Nutr
Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace
07:17am, Wednesday, 11'th Nov 2020
Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace
Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace
07:15am, Wednesday, 11'th Nov 2020
Nutra Pharma announces that its all-natural pain reliever, Nyloxin, has been accepted by the Walmart Marketplace and is now available there for purchasePlantation, Florida--(Newsfile Corp. - November
Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt
09:01am, Wednesday, 04'th Nov 2020
Plantation, Florida, November 4, 2020 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-cou
Sign In
Buy NPHC